CoreCivic Inc (CXW)
Official siteINDUSTRIALS • SECURITY & PROTECTION SERVICES • NYSE
Market Cap: $2.70B
Last updated: Nov 17, 2026 at 11:04 AM ET
CoreCivic Inc (CXW) Stock Forecast
Analysts expect CoreCivic (CXW) to earn $1.79 per share in the fiscal year ending Dec 31, 2026, on revenue of $2.78B. Of 4 analysts, 4 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 4 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 4 | 100.0% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 4
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 28.5% and revenue estimates rise 6.1%.
- Fiscal year ending Dec 31, 2026
- $1.79
- EPS consensus, revenue $2.78B
- Fiscal year ending Dec 31, 2027
- $2.30
- EPS consensus, revenue $2.95B
- Next report
- Feb 9, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $1.79 | $1.75 to $1.87 | 5 | $2.78B | $2.74B to $2.80B | 5 |
| Dec 31, 2027 | $2.30 | $1.97 to $2.66 | 5 | $2.95B | $2.83B to $3.02B | 5 |
Quarterly Estimates
The EPS consensus rises from $0.50 for the quarter ending Dec 31, 2026 to $0.57 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.50 | $0.42 to $0.56 | 7 | $732.13M | $681.10M to $791.28M | 7 |
| Mar 31, 2027 | $0.57 | $0.48 to $0.65 | 2 | $718.32M | $700.00M to $736.64M | 2 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 3 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
| Quarter ending Mar 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 5.9% from $1.69.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $1.79 | $1.69 | $1.68 | $1.69 | $1.69 | +6.2% |
| Fiscal year ending Dec 31, 2027 | $2.30 | $2.48 | $2.42 | $2.28 | $2.28 | +0.9% |
| Quarter ending Mar 31, 2027 | $0.57 | $0.59 | $0.59 | $0.57 | $0.57 | -0.9% |
Frequently Asked Questions About CXW
What is the CXW stock forecast?
Consensus analyst estimates put CoreCivic's EPS at $1.79 for the fiscal year ending Dec 31, 2026, on revenue of $2.78B. The consensus rating from 4 analysts is Buy.
How do analysts rate CXW stock?
Of 4 analysts covering CoreCivic, 0 rate it Strong Buy, 4 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from CXW next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $1.79, with estimates from $1.75 to $1.87 from 5 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $2.30, with estimates from $1.97 to $2.66 from 5 analysts.
What revenue do analysts expect from CoreCivic next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $2.78B, with estimates from $2.74B to $2.80B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $2.95B, with estimates from $2.83B to $3.02B.
How many analysts cover CXW?
4 analysts rate CoreCivic stock, and 5 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
CXW pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts